期刊文献+

微小RNA-199a在胃癌中的表达及临床意义 被引量:7

Clinical significance of microRNA-199a expression in gastric cancer
原文传递
导出
摘要 目的探讨miR-199a-3p和miR-199a-5p在胃癌中的表达及其与临床病理特征的关系。方法提取32例胃癌及其癌旁正常胃黏膜组织标本的总RNA,采用茎环逆转录实时定量聚合酶链反应(PCR)方法检测miR-199a-3p和miR-199a-5p的表达量,并分析其与分化程度、淋巴结转移等临床病理特征的关系。结果与癌旁正常胃黏膜组织比较,miR-199a-3p和miR-199a-5p在癌组织中高表达(表达值中位数分别为2.07和1.97,P〈0.05),其中miR-199a-3p的表达与胃癌的淋巴结转移状态(P〈0.01)、肿瘤分化程度(P〈0.01)及TNM分期(P〈0.05)相关;miR-199a-Sp的表达与肿瘤分化程度(P〈0.01)及肿块部位相关(P〈0.05),ROC曲线分析显示,miR-199a-3p和miR-199a-5p评价胃癌细胞分化程度的特异性和敏感性均为71.4%和93.3%。结论miR-199a-3p和miR-199a-Sp在胃癌中的异常表达可能与胃癌的发生发展有关。 Objective To'investigate the expression of miR-199a-3p and miR-199a-5p and its as- sociation with clinicopathologic features in gastric cancer. Methods The expression levels of miR-199a-3p and miR-199a-Sp in 32 gastric cancers and their matched non-tumor adjacent tissue specimens were detected by using stem-loop real-time reverse transcription-polymerase chain reaction ( RT-PCR), and their correlation with clinicopathologic features of gastric cancer was analyzed. Results Expression levels of miR- 199a-3p and miR-199a-Sp were significantly higher in tumor tissues than in adjacent normal tissues (P 〈 0.05 ). The expression of miR-199a-3p was associated with lymph node metastasis positively (P 〈 0.01 ), TNM stage (P 〈 0. 05 ) and cell differentiation (P 〈 0.01 ). The expressions of miR-199a-5p was associated with cell differentiation ( P 〈 0. 01 ) and location ( P 〈 0. 05 ). ROC curve of miR-199a-3p and miR- 199a-5p about cell differentiation resulted in a diagnostic sensitivity of 93.3% and spectificity of 71.4%. Conclusion The level of miR-199a-3p and miR-199a-5p expression may be a valuable adjuvant parameter in forecasting the poorly differentiated gastric cancer.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第12期2145-2147,共3页 Chinese Journal of Experimental Surgery
基金 基金项目:浙江省自然科学基金资助项目(Y2080978) 温州市科技局资助项目(Y20070067) 温州市科技局资助项目(H20100028)
关键词 MIRNA 胃癌 细胞分化 microRNA Gastric carcinoma Cell differentiation
  • 相关文献

参考文献4

二级参考文献13

  • 1向欣,黄正松,石忠松,夏之柏,胡斌,廖冰.脑星形细胞瘤Livin基因表达与细胞增殖的关系[J].中华实验外科杂志,2005,22(9):1141-1141. 被引量:15
  • 2Jacobs TW,Gowll AM,Yaziji H,et al. Specificity of hercep test in determing her- 2/ NEU status of breast cancers using the united states food and drug administration- approved scoring system. Journal of Clinical Oncology, 1999,17 : 1983.
  • 3Plowman GD, Culouscou JM, Whitney GS, et al. Ligand-specific activation of HER4/ P180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA, 1993,90 : 1746.
  • 4Srinivasan R,Poulsom R, Hurst HC, et al. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol,1998 ,185 :236.
  • 5Li W,Park JW,Nuijens A,et al. Heregulin is rapidly translocated to the nucleus and its transprot is correlated with c-myc induction in breast cancer cells. Oncogene, 1996,12:2473.
  • 6Junttila TT, Sundvall M, Lundin M, et al. Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Res ,2005,65 : 1384.
  • 7Kountourakis P,Pavlakis K,Psyrri A,et al. Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas, BMC Cancer ,2006,28:6:46.
  • 8Du C, Fang M, Li Y, et al. Smac,a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell ,2000,102:33-42.
  • 9Yoo N J, Kim HS, Kim SY, et al. Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas. APMIS ,2003,111:382-388.
  • 10Ma L, Huang Y, Song Z, et al. Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway. Cell Death Differ, 2006, 13: 2079-2088.

共引文献15

同被引文献52

  • 1孙凯,黄晓卉,甄茂川,汪谦.应用液相芯片分析肝细胞癌及癌旁组织小分子RNA表达谱差异[J].中华实验外科杂志,2006,23(8):945-947. 被引量:25
  • 2左石,罗剑,刘民锋,徐立宁,董泾青,郭伟,邹声泉.DNA甲基转移酶1、3b基因共下调对人胆管癌细胞生长的抑制效应[J].中华实验外科杂志,2006,23(8):912-915. 被引量:12
  • 3Moe RE,Anderson BO. Androgens and androgen receptors:A clinical- ly neglected sector in breast cancer biology. J Surg Oncol, 2007,95 : 437-439.
  • 4Yu Q, Niu Y, Liu N, et al. Expression of androgen receptor in breast cancer and its significance as a prognostic factor. Ann Oncol, 2011, 22 : 1288-1294.
  • 5Peters AA, Buchanan G, Ricciardelli C, et al. Androgen receptor in- hibits estrogen receptor-alpha activity and is prognostic in breast cane- er. Cancer Res ,2009,69:6131-6140.
  • 6Hall RE, Birrell SN, Tilley WD, et al. MDA-MB-453, an androgen-re- sponsive human breast carcinoma cell line with high level androgen re- ceptor expression. Eur J Cancer, 1994,30A :484-490.
  • 7Melo SA, Esteller M. Dysregulation of mi- croRNAs in cancer: Playing with fire. FEBS Lett,2011,585:2057-2099.
  • 8Breving K, Esquela-Kerscher A. The com- plexities of microRNA regulation: miran- dering around the rules. Int J Biochem Cell Biol,2010,42 : 1316-1329.
  • 9Shalgi R, Pilpel Y, Oren M. Repression of transposable-elements-a microRNA anti- cancer defense mechanism?. Trends Gen- et,2010,26:253-259.
  • 10Iorio MV, Piovan C, Croce CM. Interplaybetween microRNAs and the epigenetic machinery:an intricate network. Biochim Biophys Acta,2010,1799:694-701.

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部